Advertisement

Employment of Salmonella in Cancer Gene Therapy

  • Che-Hsin Lee
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1409)

Abstract

One of the primary limitations of cancer gene therapy is lack of selectivity of the therapeutic gene to tumor cells. Current efforts are focused on discovering and developing tumor-targeting vectors that selectively target only cancer cells but spare normal cells to improve the therapeutic index. The use of preferentially tumor-targeting bacteria as vectors is one of the innovative approaches for the treatment of cancer. This is based on the observation that some obligate or facultative-anaerobic bacteria are capable of multiplying selectively in tumors and inhibiting their growth. In this study, we exploited attenuated Salmonella as a tumoricidal agent and a vector to deliver genes for tumor-targeted gene therapy. Attenuated Salmonella, carrying a eukaryotic expression plasmid encoding an anti-angiogenic gene, was used to evaluate its’ ability for tumor targeting and gene delivery in murine tumor models. We also investigated the use of a polymer to modify or shield Salmonella from the pre-existing immune response in the host in order to improve gene delivery to the tumor. These results suggest that tumor-targeted gene therapy using Salmonella carrying a therapeutic gene, which exerts tumoricidal and anti-angiogenic activities, represents a promising strategy for the treatment of tumors.

Key words

Salmonella Tumor targeting Gene therapy Polymer Antitumor 

References

  1. 1.
    Pawelek JM, Low KB, Bermudes D (2003) Bacteria as tumour-targeting vectors. Lancet Oncol 4:548–556CrossRefPubMedGoogle Scholar
  2. 2.
    Pawelek JM, Low KB, Bermudes D (1997) Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res 57:4537–4544PubMedGoogle Scholar
  3. 3.
    Zhao M, Yang M, Li XM, Jiang P, Baranov E, Li S, Xu M, Penman S, Hoffman RM (2005) Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc Natl Acad Sci U S A 102:755–760PubMedCentralCrossRefPubMedGoogle Scholar
  4. 4.
    Lee CH, Wu CL, Shiau AL (2004) Endostatin gene therapy delivered by Salmonella choleraesuis in murine tumor models. J Gene Med 6:1382–1393CrossRefPubMedGoogle Scholar
  5. 5.
    Dang LH, Bettegowda C, Huso DL, Kinzler KW, Vogelstein B (2001) Combination bacteriolytic therapy for the treatment of experimental tumors. Proc Natl Acad Sci U S A 98:15155–15160PubMedCentralCrossRefPubMedGoogle Scholar
  6. 6.
    Yazawa K, Fujimori M, Amano J, Kano Y, Taniguchi S (2000) Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors. Cancer Gene Ther 7:269–274CrossRefPubMedGoogle Scholar
  7. 7.
    Lee CH, Wu CL, Tai YS, Shiau AL (2005) Systemic administration of attenuated Salmonella choleraesuis in combination with cisplatin for cancer therapy. Mol Ther 11:707–716CrossRefPubMedGoogle Scholar
  8. 8.
    Lee CH, Hsieh JL, Wu CL, Hsu PY, Shiau AL (2011) T cell augments the antitumor activity of tumor-targeting Salmonella. Appl Microbiol Biotechnol 90:1381–1388CrossRefPubMedGoogle Scholar
  9. 9.
    Liu F, Zhang L, Hoffman RM, Zhao M (2010) Vessel destruction by tumor-targeting Salmonella typhimurium A1-R is enhanced by high tumor vascularity. Cell Cycle 9:4518–4524PubMedCentralCrossRefPubMedGoogle Scholar
  10. 10.
    Nagakura C, Hayashi K, Zhao M, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, Bouvet M, Hoffman RM (2009) Efficacy of a genetically-modified Salmonella typhimurium in an orthotopic human pancreatic cancer in nude mice. Anticancer Res 29:1873–1878PubMedGoogle Scholar
  11. 11.
    Lee CH, Wu CL, Shiau AL (2005) Systemic administration of attenuated Salmonella choleraesuis carrying thrombospondin-1 gene leads to tumor-specific transgene expression, delayed tumor growth and prolonged survival in the murine melanoma model. Cancer Gene Ther 12:175–182CrossRefPubMedGoogle Scholar
  12. 12.
    Ganai S, Arenas RB, Forbes NS (2009) Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice. Br J Cancer 101:1683–1691PubMedCentralCrossRefPubMedGoogle Scholar
  13. 13.
    Lee CH, Wu CL, Chen SH, Shiau AL (2009) Humoral immune responses inhibit the antitumor activities mediated by Salmonella enterica serovar Choleraesuis. J Immunother 32:376–388CrossRefPubMedGoogle Scholar
  14. 14.
    Lee CH, Lin YH, Hsieh JL, Chen MC, Kuo WL (2013) A polymer coating applied to Salmonella prevents the binding of Salmonella-specific antibodies. Int J Cancer 132:717–725CrossRefPubMedGoogle Scholar
  15. 15.
    Lee CH (2012) Engineering bacteria toward tumor targeting for cancer treatment: current state and perspectives. Appl Microbiol Biotechnol 93:517–523CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Department of Microbiology, School of MedicineChina Medical UniversityTaichungTaiwan
  2. 2.Department of Biological SciencesNational Sun Yat-sen UniversityKaohsiungTaiwan

Personalised recommendations